Mentalyc

Bottom line

Mentalyc generates therapy progress notes in DAP, SOAP, BIRP, and GIRP formats from session audio, targeting solo therapists and small group practices at $19.99 to $69.99 per month. It offers HIPAA compliance and a therapist referral program, positioning itself as a therapy-specific alternative to general medical AI scribes. The tool aims to reduce documentation burden for mental health clinicians who face high note-writing volume and burnout risk.

The price point and therapy-focused workflow make Mentalyc accessible for solo practitioners operating outside large health systems. However, the evidence base is exceptionally thin: zero peer-reviewed publications and minimal clinician feedback in public forums. Buyers should treat this as an early-stage tool with unproven reliability in real-world clinical documentation workflows.

Best fit for solo therapists willing to experiment with AI documentation tools and accept uncertain note quality during the adoption phase. Large group practices, integrated delivery networks, and evidence-driven buyers should wait for published validation studies and broader clinician adoption data before committing.

Why we picked it

Mentalyc earned a silo pick in the AI Mental Health category as the best therapy-specific AI scribe because it addresses a genuine pain point: therapists write more progress notes per week than most other specialties, and the formats (DAP, SOAP, BIRP, GIRP) are standardized enough to be machine-learnable but tedious enough to cause clinician burnout. General medical scribes such as Two Fold and Heidi were built for primary care and hospitalist workflows, which differ meaningfully from psychotherapy documentation patterns. Therapy sessions are longer, the narrative arc is different, and the note format often requires reflective synthesis rather than diagnostic reasoning chains.

The tool's pricing structure ($19.99 to $69.99 per month) sits well below enterprise ambient scribe platforms that target hospital systems at per-encounter fees or annual contracts measured in thousands of dollars. This makes it viable for solo practitioners and small group practices that operate on tight margins and cannot justify enterprise software budgets. The referral program signals a grassroots growth strategy that prioritizes therapist word-of-mouth over institutional sales cycles.

HIPAA compliance is table stakes for any mental health documentation tool, and Mentalyc meets this minimum requirement. The absence of higher-tier certifications such as SOC 2 Type II or HITRUST is notable but not disqualifying for small practices that lack compliance audit teams. Solo therapists often rely on vendor self-attestation rather than independent audits when selecting software.

The tool's focus on session audio as the input modality aligns with how many therapists already work: some record sessions (with patient consent) for supervision or quality assurance, and converting those recordings into structured notes is a logical automation target. The question is whether the AI reliably captures therapeutic content, patient safety concerns, and treatment plan updates without requiring extensive human editing. The evidence on that question remains sparse.

What it does well

Mentalyc supports the four most common therapy progress note formats: DAP (Data, Assessment, Plan), SOAP (Subjective, Objective, Assessment, Plan), BIRP (Behavior, Intervention, Response, Plan), and GIRP (Goals, Intervention, Response, Plan). Each format has specific clinical use cases. DAP and SOAP are widely used across outpatient mental health settings, while BIRP and GIRP are favored in settings that emphasize treatment plan adherence and goal tracking. Offering all four formats in one platform reduces the need for therapists to maintain multiple documentation workflows or reformat notes manually when switching between clinical settings or payer requirements.

The session audio input modality matches how many therapists already document: record the session, then write notes afterward from memory or audio review. Mentalyc automates the second step by transcribing audio and generating structured notes. This is faster than typing freehand notes and may improve note completeness if the AI reliably extracts relevant clinical content. The workflow is straightforward: upload or record audio, select note format, review and edit the generated output, then copy the final note into the EHR or practice management system.

The pricing tier starts at $19.99 per month, making it accessible for early-career therapists, part-time clinicians, and solo practitioners who cannot afford enterprise ambient scribe platforms. A therapist writing 20 notes per week at 10 minutes per note spends over 3 hours weekly on documentation. If Mentalyc reduces that by even 50 percent, the time savings justify the cost within the first billing cycle. The upper pricing tier at $69.99 per month likely reflects higher note volume limits or additional features, though the vendor does not publicly document tier differences in detail.

The therapist referral program creates a community-driven adoption pathway. Therapists who recommend Mentalyc to colleagues may receive account credits or reduced subscription fees, which incentivizes word-of-mouth validation among trusted peer networks. This contrasts with top-down enterprise sales models and may accelerate adoption in private practice settings where purchasing decisions are individual rather than institutional.

Where it falls short

The most significant limitation is the absence of peer-reviewed evidence. Zero PubMed-indexed studies validate Mentalyc's note accuracy, safety, or clinical utility. This stands in stark contrast to FDA-cleared ambient scribe platforms such as DAX Copilot, which have undergone clinical validation and regulatory review. Without published studies, buyers must rely entirely on vendor claims and anecdotal feedback when assessing whether the tool generates clinically reliable notes. For evidence-driven practices and hospital systems, this is a nonstarter.

Public clinician feedback is equally scarce. A search across Reddit health informatics and medical communities yielded only one mention: a clinician asking whether to choose a general AI scribe (Two Fold, Heidi) or a therapy-specific tool (Supanote, Mentalyc). The post did not include firsthand experience with Mentalyc, only a question about category fit. This lack of organic clinician discussion suggests either very low adoption or limited community engagement. Tools with strong real-world performance typically generate more spontaneous feedback in clinician forums.

EHR integration depth is unclear. The vendor website does not specify whether Mentalyc integrates bidirectionally with major EHR platforms (Epic, Cerner Oracle Health, athenahealth, eClinicalWorks) or requires manual copy-paste workflows. For solo practitioners using simple practice management systems, manual copy-paste may be acceptable. For clinicians in group practices or integrated delivery networks, lack of native EHR integration creates workflow friction and reduces time savings. Buyers should confirm integration capabilities before committing to annual contracts.

The pricing structure lacks transparency. The $19.99 to $69.99 range spans nearly a 3.5x difference, but the vendor does not publicly document what drives the variation. Possible factors include note volume limits, feature access tiers, or per-user licensing in group practices. Without clear tier definitions, buyers cannot accurately forecast costs as their practice grows or their documentation volume increases. Hidden fees for API calls, audio storage, or customer support could push total cost of ownership above the advertised range.

Deployment realities

Deployment complexity depends on EHR integration depth. If Mentalyc offers native integration with the practice's EHR or practice management system, deployment involves account setup, user authentication, and workflow training. If integration is absent, the workflow becomes: record or upload session audio to Mentalyc, generate the note, review and edit in the Mentalyc interface, then copy-paste the final note into the EHR. The copy-paste step introduces workflow friction and increases the risk of transcription errors or incomplete note transfer. Practices should test the integration pathway during a trial period before signing annual contracts.

Training time for solo therapists is likely minimal. The core workflow (upload audio, select format, review output) is simple enough to learn in a single session. Group practices may need standardized training protocols to ensure consistent note quality across clinicians, especially if different therapists use different note formats or have varying tolerance for AI-generated content. Change management risk is low because documentation is already a pain point; therapists are motivated to adopt tools that reduce note-writing time.

IT requirements are minimal for cloud-based deployment. Mentalyc appears to operate as a web application, which eliminates on-premises server setup and network configuration. The primary IT concern is HIPAA compliance: practices must verify that Mentalyc signs a Business Associate Agreement and that audio uploads and note storage meet encryption and access control standards. Solo practitioners without dedicated IT staff should confirm that the vendor handles security updates and compliance monitoring without requiring in-house technical expertise.

Pricing realities

The advertised pricing range is $19.99 to $69.99 per month per clinician. The lower tier likely targets solo practitioners with modest note volumes, while the upper tier may support higher note counts or add features such as team collaboration, audit logs, or priority support. Without public tier documentation, buyers must contact the vendor for a detailed pricing matrix. This opacity complicates budget forecasting, especially for group practices that need to estimate per-clinician costs at scale.

Hidden costs may include audio storage fees if the platform retains session recordings beyond a trial period, per-API-call charges if the tool integrates with third-party EHR systems, or onboarding and training fees for group practices. Annual contracts may offer discounts compared to month-to-month billing, but they also lock practices into a tool with limited independent validation. Buyers should request a full cost breakdown including storage, support, and integration fees before committing.

ROI calculation hinges on time savings per note. If a therapist spends 10 minutes per note and writes 20 notes per week, that is 200 minutes (3.3 hours) weekly. At a clinician billing rate of $150 per hour, the opportunity cost is approximately $500 per week or $2,000 per month. If Mentalyc reduces documentation time by 50 percent, it saves 100 minutes weekly, worth roughly $1,000 per month. At $69.99 per month, the tool pays for itself if it delivers even modest time savings. However, this calculation assumes the AI-generated notes require minimal editing and do not introduce new quality assurance overhead.

Compliance + integration depth

Mentalyc is HIPAA compliant, which is the minimum regulatory threshold for handling protected health information in the United States. HIPAA compliance requires encryption of data in transit and at rest, access controls, audit logging, and a signed Business Associate Agreement. The vendor's website confirms HIPAA compliance, but it does not specify whether the platform has undergone independent third-party audits such as SOC 2 Type II or HITRUST certification. These higher-tier certifications are often required by hospital systems and integrated delivery networks that face stricter compliance scrutiny.

The tool does not appear to have FDA clearance or 510(k) approval. AI-based clinical decision support tools that diagnose, treat, or prevent disease typically require FDA review, but ambient scribe platforms that assist with documentation may fall outside that scope depending on their claims and functionality. Mentalyc positions itself as a documentation assistant rather than a diagnostic tool, which likely places it in a lower regulatory risk category. However, buyers in highly regulated environments should confirm the tool's regulatory status with internal compliance teams before deployment.

EHR integration specifics are not documented on the vendor's public-facing website. Buyers should ask whether Mentalyc supports bidirectional data exchange with their EHR (Epic, Cerner Oracle Health, athenahealth, Nextgen, eClinicalWorks) or whether notes must be copied manually. Read-only integrations that pull patient demographic data are useful but do not reduce workflow friction. Write-back integrations that push completed notes directly into the EHR are significantly more valuable. The depth of integration determines whether Mentalyc becomes a seamless part of the clinical workflow or an external tool that adds steps to the documentation process.

Vendor stability + roadmap

Mentalyc Inc. is a US-based company, but public information about funding rounds, leadership team, or acquisition history is sparse. The vendor's website does not list investors, board members, or customer case studies, which makes it difficult to assess long-term stability. Early-stage startups in the AI healthcare space often face cash flow challenges and may pivot, shut down, or be acquired before reaching product-market fit. Buyers should ask for customer references and inquire about the vendor's runway and customer retention rates before committing to annual contracts.

The therapist referral program suggests a grassroots growth strategy focused on private practice adoption rather than enterprise sales. This model can build strong community loyalty but may limit revenue growth compared to platforms that target hospital systems and integrated delivery networks. If Mentalyc remains focused on solo practitioners and small group practices, it may struggle to fund the engineering and compliance infrastructure needed to compete with enterprise ambient scribe platforms backed by major health IT vendors.

The product roadmap is not publicly documented. Buyers should ask whether Mentalyc plans to add EHR integrations, expand beyond mental health specialties, or introduce enterprise features such as group analytics, supervisor review workflows, or multi-site deployment. A vendor with a clear roadmap and transparent communication cadence is more likely to deliver sustained product improvements than one that operates in stealth mode.

How it compares

Two Fold and Heidi are general-purpose medical AI scribes that serve primary care, urgent care, and hospitalist workflows. They generate SOAP notes and other common clinical documentation formats but are not optimized for psychotherapy-specific formats such as DAP, BIRP, or GIRP. Two Fold integrates with major EHR platforms and offers ambient audio capture via mobile apps, making it suitable for clinicians who need cross-specialty documentation support. Heidi similarly targets multi-specialty practices and emphasizes EHR integration depth. Both tools are better fits for primary care clinicians or hospitalists who treat diverse patient populations and need flexible documentation templates.

Supanote is a direct competitor in the therapy-specific AI scribe category. Like Mentalyc, it focuses on psychotherapy progress notes and markets to solo practitioners and group practices. The Reddit clinician who asked about Mentalyc versus Supanote was evaluating both tools for therapy-specific reliability. Without firsthand clinician feedback comparing the two platforms, it is difficult to determine which produces higher-quality notes or offers better workflow integration. Buyers should request trial access to both platforms and compare note accuracy, editing burden, and EHR integration capabilities side by side.

DAX Copilot, developed by Nuance (a Microsoft company), is the gold standard for ambient clinical documentation in the United States. It has FDA clearance, published validation studies, and deep integration with Epic and other major EHR platforms. DAX Copilot is significantly more expensive than Mentalyc, often priced on a per-encounter basis or as part of enterprise EHR licensing agreements. It serves hospital systems and large medical groups rather than solo practitioners. Mentalyc wins on price and accessibility; DAX Copilot wins on evidence, regulatory clearance, and enterprise integration.

For solo therapists on tight budgets who prioritize therapy-specific note formats and are willing to accept early-stage tool risk, Mentalyc is a reasonable choice. For primary care clinicians or hospitalists who need multi-specialty documentation support, Two Fold or Heidi are better fits. For integrated delivery networks and evidence-driven practices that require published validation and FDA clearance, DAX Copilot remains the safest option despite its higher cost.

What clinicians say

Public clinician feedback on Mentalyc is extremely limited. A search of Reddit health informatics and medical communities yielded only one relevant mention: a clinician on r/HealthInformatics asked whether to choose a general AI scribe such as Two Fold or Heidi versus a therapy-specific tool such as Supanote or Mentalyc. The question focused on reliability of output and alignment with therapist workflows. The post did not include firsthand experience with Mentalyc, only a question about category fit. The sentiment was neutral, reflecting genuine uncertainty about whether therapy-specific tools outperform general medical scribes for mental health documentation.

The absence of organic clinician discussion in public forums is notable. Tools with strong real-world performance and broad adoption typically generate spontaneous feedback in Reddit communities such as r/medicine, r/Psychiatry, and r/TherapyPro. Clinicians share workflow tips, compare platforms, and report bugs or success stories. The silence around Mentalyc suggests either very low adoption, limited community engagement, or early-stage deployment that has not yet reached critical mass in clinician networks.

Buyers should request customer references from the vendor and ask to speak with practicing therapists who use Mentalyc in daily clinical workflows. Specific questions to ask references include: How much editing do AI-generated notes require? Does the tool reliably capture safety concerns and treatment plan changes? How does it handle ambiguous or complex session content? What is the vendor's responsiveness when note quality issues arise? Without independent clinician validation, buyers are relying on vendor marketing claims and should proceed cautiously.

What the literature says

Mentalyc has zero peer-reviewed publications indexed in PubMed as of May 2026. No validation studies, accuracy benchmarks, or clinical utility assessments have been published in medical or health informatics journals. This stands in stark contrast to FDA-cleared ambient scribe platforms such as DAX Copilot, which have undergone clinical validation and regulatory review. The absence of published evidence means that claims about note accuracy, time savings, and clinical safety are based solely on vendor assertions rather than independent scientific evaluation.

The lack of peer-reviewed evidence is a major limitation for evidence-driven practices, academic medical centers, and integrated delivery networks that require published validation before adopting clinical documentation tools. These organizations face liability risk if AI-generated notes contain errors or omit critical clinical information, and they rely on published studies to assess that risk. Solo practitioners and small group practices may accept vendor self-attestation, but larger institutions typically cannot.

The evidence gap also limits the ability to compare Mentalyc to competitor platforms on objective quality metrics. Without published benchmarks for note accuracy, completeness, or editing burden, buyers must conduct their own internal pilots and collect their own performance data. This increases adoption risk and extends the evaluation timeline. Buyers should ask the vendor whether validation studies are in progress and when results are expected to be published in peer-reviewed journals.

Who it's for

Mentalyc is best suited for solo therapists and small group practices that operate outside large health systems, prioritize therapy-specific note formats (DAP, SOAP, BIRP, GIRP), and face high documentation burden. Ideal users include licensed clinical social workers, licensed professional counselors, psychologists, and psychiatrists in outpatient private practice settings who write 15 to 30 progress notes per week and spend 2 to 4 hours weekly on documentation. The $19.99 to $69.99 per month price point fits budgets for early-career therapists and part-time clinicians who cannot justify enterprise software costs.

The tool is also appropriate for therapists who already record sessions with patient consent for supervision or quality assurance purposes. If session audio is already being captured, converting it to structured notes via Mentalyc is a logical workflow extension. Therapists who do not record sessions will need to change their documentation process, which may introduce patient consent and workflow friction.

Mentalyc is not appropriate for integrated delivery networks, hospital-based mental health clinics, or evidence-driven practices that require published validation studies and FDA clearance before adopting clinical documentation tools. Large group practices that need deep EHR integration, audit trails, and supervisor review workflows should confirm that Mentalyc supports those features before committing. Clinicians in specialties outside mental health (primary care, urgent care, hospitalist medicine) should choose general-purpose medical scribes such as Two Fold, Heidi, or DAX Copilot that support broader clinical documentation needs.

The verdict

Mentalyc addresses a real clinical pain point for solo therapists: high documentation burden, standardized note formats, and tight budgets. The tool's focus on therapy-specific workflows (DAP, SOAP, BIRP, GIRP) and accessible pricing ($19.99 to $69.99 per month) differentiate it from general medical scribes and enterprise ambient platforms. However, the evidence base is exceptionally thin. Zero peer-reviewed publications and minimal clinician feedback in public forums mean that buyers are adopting an unproven tool with uncertain note quality and reliability.

Solo therapists who are comfortable with early-stage technology risk and willing to invest time in piloting the tool may find value if Mentalyc reduces documentation time by 30 to 50 percent with minimal editing burden. Buyers should start with a month-to-month subscription rather than an annual contract, conduct a 30-day internal pilot, and track time savings and note quality metrics before scaling adoption. If AI-generated notes require extensive editing or miss critical clinical content, the time savings evaporate and the tool becomes a workflow burden rather than an efficiency gain.

Evidence-driven practices, hospital systems, and integrated delivery networks should wait for published validation studies and broader clinician adoption before committing to Mentalyc. The absence of peer-reviewed evidence, unclear EHR integration depth, and limited vendor transparency around pricing tiers and compliance certifications create adoption risk that is difficult to justify without independent validation. For these buyers, DAX Copilot remains the safer choice despite its higher cost, or they should wait for Mentalyc to publish validation data and achieve SOC 2 or HITRUST certification. Solo practitioners willing to experiment can proceed cautiously; institutional buyers should hold off.